Kaken Pharmaceutical Co Ltd

TSE:4521

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is Kaken Pharmaceutical Co Ltd's stock price target?

Price Target

3 570 JPY

According to Wall Street analysts, the average 1-year price target for Kaken Pharmaceutical Co Ltd is 3 570 JPY with a low forecast of 3 535 JPY and a high forecast of 3 675 JPY.

What is Kaken Pharmaceutical Co Ltd's Revenue forecast?

Projected CAGR

-3%

For the last 8 years the compound annual growth rate for Kaken Pharmaceutical Co Ltd's revenue is -3%. The projected CAGR for the next 3 years is -3%.

What is Kaken Pharmaceutical Co Ltd's Net Income forecast?

Projected CAGR

-1%

For the last 8 years the compound annual growth rate for Kaken Pharmaceutical Co Ltd's net income is -10%. The projected CAGR for the next 3 years is -1%.